• Proposed non-underwritten rights issue of up to 596,532,580 Rights Shares on a 1-for-2 basis at HK$ 0.068 each.
• Gross proceeds up to about HK$ 40 million; net proceeds up to about HK$ 39 million, assuming full subscription.
• Shares traded ex-rights from July 24, 2026; nil-paid rights expected to trade Aug. 6-13, 2026.
• Acceptance and payment deadline set for 4:00 p.m. on Aug. 18, 2026; fully-paid Rights Shares expected to begin trading Sept. 9, 2026.
• Any unsubscribed rights to be placed to independent investors on a best-efforts basis; unplaced shares will not be issued, shrinking the deal size.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosysen Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260804-12269853), on August 03, 2026, and is solely responsible for the information contained therein.